Stock SYRE SPYRE THERAPEUTICS, INC.
Add to a list
To use this feature you must be a member
Log inSign up

Revisions Spyre Therapeutics, Inc.

Equities

SYRE

US00773J2024

Real-time Estimate Cboe BZX
Other stock markets
 12:40:33 2024-05-23 pm EDT 		5-day change 1st Jan Change
33.36 USD -6.17% Intraday chart for Spyre Therapeutics, Inc. -12.42% +53.83%
May. 15 Spyre Therapeutics, Inc. Announces Board Changes CI
May. 13 Wells Fargo Adjusts Price Target on Spyre Therapeutics to $40 From $35, Maintains Overweight Rating MT

Turnover - Change in analysts' estimates

Earnings Per Share (EPS) - Change in analysts' estimates

EBIT - Change in analysts' estimates

Cash or Net Debt - Change in analysts' estimates

Turnover

Earnings Per Share (EPS)

EBIT

Cash or Net Debt

  1. Stock Market
  2. Equities
  3. SYRE Stock
  4. Revisions Spyre Therapeutics, Inc.